5-Aminoisoquinolinone reduces colon injury by experimental colitis

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 370, Issue 6, 2004, Pages 464-473

  Cuzzocrea, Salvatore ^a   Mazzon, Emanuela ^a   Di Paola, Rosanna ^a   Genovese, Tiziana ^a   Patel, Nimesh S A ^b   Muià, Carmelo ^a   Threadgill, Michael D ^c   De Sarro, Angelina ^a   Thiemermann, Christoph ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c University of Bath   (United Kingdom)

Author keywords

5 AIQ; Colitis; ICAM 1; Inflammatory infiltration; PARP

Indexed keywords

3 AMINOBENZAMIDE; 5 AMINOISOQUINOLINONE; INTERCELLULAR ADHESION MOLECULE 1; MYELOPEROXIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; COLON INJURY; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; ENZYME ACTIVITY; GASTROINTESTINAL HEMORRHAGE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MUCOSA; NECROSIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; STAINING; UPREGULATION; WEIGHT REDUCTION;

ANIMALS; COLITIS; COLON; DINITROFLUOROBENZENE; ISOQUINOLINES; MALE; MICE;

EID: 12144251200     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-004-1002-x     Document Type: Article

References (57)

1. Aiko S, Grisham MB (1995) Spontaneous intestinal inflammation and nitric oxide metabolism in HLA-B27 transgenic rats. Gastroenterology 109:142-150
2. Appleyard CB, Wallace JL (1995) Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol 269:G119-G125
3. Banasik M, Komura H, Shimoyama M (1992) Specific inhibitors of poly (ADP-ribose)synthetase and mono (ADP-ribose) transferase. J Biol Chem 267:1569-1575
4. Berger NA (1985) Poly(ADP-ribose) in the cellular response to DNA damage. Radiat Res 101:4-15
5. Boughton-Smith NK, Evans SM, Hawkey CJ (1993) Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 341:338-340
6. Chatterjee PK, Zacharowski K, Cuzzocrea S, Otto M, Thiemermann C (2000) Inhibitors of poly (ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo. FASEB J 14:641-651
7. Chiarugi A (2002) Poly(ADP-ribose) polymerase: killer or conspirator? The 'suicide hypothesis' revisited. Trends Pharmacol Sci 23:22-129
8. Clark WM, Lauten JD, Lessov N (1995) Time course of ICAM-1 expression and leukocyte subset infiltration in rat forebrain ischemia. Mol Chem Neuropathol 26:213-230
9. Cosi C (2002) New inhibitors of poly (ADP-ribose) polymerase and their potential therapeutic targets. Expert Opin Ther Patents 12:1047-1071
10. Cuzzocrea S, Zingarelli B, Costantino G, Szabó A, Salzman AL, Caputi AP, Szabó C (1997) Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br J Pharmacol 121:1065-1074
11. Cuzzocrea S, McDonald MC, Mazzon E (2000) The tyrosine kinase inhibitor tyrphostin AG126 reduces the development of acute and chronic inflammation. Am J Pathol 157:145-158
12. Cuzzocrea S, McDonald MC, Mazzon E (2001) Calpain inhibitor I reduces colon injury caused by dinitrobenzene sulphonic acid in the rat. Gut 48:478-488
13. Cuzzocrea S, McDonald MC, Mazzon E (2002) Effects of 5- aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury. Biochem Pharmacol 63:293-304
14. Davenpeck KL, Gauthier TW, Albertine KH (1994) Role of P-selectin in microvascular leukocyte-endothelial interaction in splanchnic ischemia-reperfusion. Am J Physiol 267:H622-H630
15. Desreumaux P, Brandt E, Gambiez L (1997) Distinct cytokine patterns in early and chronic ileal lesions of Crohn's disease. Gastroenterology 113:118-126
16. Eliasson MJ, Sampei K, Mandir AS, Hurn PD, Traystman RJ, Bao J, Pieper A, Wang ZQ, Dawson TM, Snyder SH, Dawson VL (1997) Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med 3:1089-1095
17. Farhood A, McGuire GM, Manning AM (1995) Intercellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. J Leukoc Biol 57:368-374
18. Fiocchi C (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182-205
19. Furie MB, Tancinco MC, Smith CW (1991) Monoclonal antibodies to leukocyte integrins CD11a/CD18 and CD11b/CD18 or intercellular adhesion molecule-1 inhibit chemoattractant-stimulated neutrophil transendothelial migration in vitro. Blood 78:2089-2097
20. Horie Y, Wolf R, Iyasaka M (1996) Leukocyte adhesion and hepatic microvascular responses to intestinal ischemia/reperfusion in rats. Gastroenterology 111:666-673
21. Ikai K, Ueda K (1983) Immunohistochemical demonstration of poly (adenosine diphosphate-ribose) synthetase in bovine tissues. J Histochem Cytochem 31:261-264
22. Ikeda I, Kasajima T, Ishiyama S (1997) Distribution of inducible nitric oxide synthase in ulcerative colitis. Am J Gastroenterol 92:1339-1341
23. Jijon HB, Churchill T, Malfair D (2000) Inhibition of poly(ADP-ribose) polymerase attenuates inflammation in a model of chronic colitis. Am J Physiol Gastrointest Liver Physiol 279: G641-G651
24. Kitahora T, Suzuki K, Asakura H (1988) Active oxygen species generated by monocytes and polymorphonuclear cells in Crohn's disease. Dig Dis Sci 33:951-955
25. Kukielka GL, Youker KA, Hawkins HK (1994) Regulation of ICAM-1 and IL-6 in myocardial ischemia: effect of reperfusion. Ann NY Acad Sci 723:258-270
26. Lora L, Mazzon E, Billington D (1997) Effects of cyclosporin A on paracellular and transcellular transport of horseradish peroxidase in perfused rat livers. Dig Dis Sci 42:514-521
27. Lundberg JO, Hellstrom PM, Lundberg JM (1994) Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 344:1673-1674
28. Luscinskas FW, Ding H, Lichtman AH (1995) P-selectin and vascular cell adhesion molecule 1 mediate rolling and arrest, respectively, of CD4+ T lymphocytes on tumor necrosis factor alpha-activated vascular endothelium under flow. J Exp Med 181:1179-1186
29. Mabley JG, Jagtap P, Perretti M (2001) Anti-inflammatory effects of a novel, potent inhibitor of poly (ADP-ribose) polymerase. Inflamm Res 50:561-569
30. Mazzon E, Dugo L, Li JH (2002) GPI 6150, a PARP inhibitor, reduces the colon injury caused by dinitrobenzene sulfonic acid in the rat. Biochem Pharmacol 64:327-337
31. McDonald MC, Mota-Filipe H, Wright JA, Abdelrahman M, Threadgill MD, Thompson AS, Thiemermann C (2000) Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock. Br J Pharmacol 130:843-850
32. Middleton SJ, Shorthouse M, Hunter JD (1993) Increased nitric oxide synthesis in ulcerative colitis. Lancet 341:465-466
33. Miller MJ, Thompson JH, Zhang XJ (1995) Role of inducible nitric oxide synthase expression and peroxynitrite formation in guinea pig ileitis. Gastroenterology 109:1475-1483
34. Morris GP, Beck PL, Herridge MS (1989) Hapten-induced model of chronic inflammation and ulceration in the rat. Gastroenterology 96:795-803
35. Mota-Filipe H, Sepodes B, McDonald MC (2002) The novel PARP inhibitor 5-aminoisoquinolinone reduces the liver injury caused by ischemia and reperfusion in the rat. Med Sci Monit 8: BR444-BR453
36. Mourelle M, Vilaseca J, Guarner F (1996) Toxic dilatation of colon in a rat model of colitis is linked to an inducible form of nitric oxide synthase. Am J Physiol 33:G425-G430
37. Mullane KM, Kraemer R, Smith B (1985) Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14:157-167
38. Mulligan MS, Polley MJ, Bayer RJ (1992) Neutrophil-dependent acute lung injury. Requirement for P-selectin (GMP-140). J Clin Invest 90:1600-1607
39. Nathan C (1996) Nitric oxide as a secretory product of mammalian cells. FASEB J 6:3051-3064
40. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
41. Ribbons KA, Zhang XJ, Thompson JH (1995) Potential role of nitric oxide in a model of chronic colitis in rhesus macaques. Gastroenterology 108:705-711
42. Shiratora Y, Aoki S, Takada H (1989) Oxygen-derived free radical generating capacity of polymorphonuclear cells in patients with ulcerative colitis. Digestion 44:163-171
43. Shreeniwas R, Koga S, Karakurum M (1992) Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Invest 90:2333-2339
44. Sturiale S, Barbara G, Qiu B (1999) Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci USA 96:11653-11658
45. Suto MJ, Turner WR, Arundel-Suto CM (1991) Dihydroisoquinolinones: the design and synthesis of a new series of potent inhibitors of poly (ADP-ribose) polymerase. Anticancer Drug Des 6:107-117
46. Szabó C, Dawson VL (1998) Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 19:287-298
47. Szabó C, Cuzzocrea S, Zingarelli B (1997) Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite. J Clin Invest 100:723-735
48. Szabó G, Bährle S, Stumpf N (2002) Poly (ADP-ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res 90:100-106
49. Takazoe M, Tanaka T, Kondo K (2002) The present status and recent development of the treatment for inflammatory bowel diseases: desirable effect of extracorporeal immunomodulation. Ther Apher 6:305-311
50. Thiemermann C (2002) Development of novel, water-soluble inhibitors of poly (adenosine 5′-diphosphate ribose) synthetase activity for use in shock and ischemia-reperfusion injury. Crit Care Med 30:1163-1165
51. Wallace JL, Keenan CM, Gale D (1992) Exacerbation of experimental colitis by non-steroidal antinflammatory drugs is not related to elevated leukotriene B4 synthesis. Gastroenterology 102:18-27
52. Wayman NS, McDonald MC, Thompson AC (2001) 5-Aminoisoquinolinone, a potent inhibitor of poly (adenosine 5′diphosphate ribose) polymerase, reduces myocardial infarct size. Eur J Pharmacol 430:93-100
53. Wenkert E, Johnston DBR, Dave KG (1964) Derivatives of hemimellitic acid. A synthesis of erythrocentaurin. J Org Chem 29:2534-2542
54. Zingarelli B, Squadrito F, Graziani P (1993) Effects of zileuton, a new 5-lipoxygenase inhibitor, in experimentally induced colitis in rats. Agents Actions 39:150-156
55. Zingarelli B, Salzman AL, Szabó C (1998) Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ Res 83:85-94
56. Zingarelli B, Szabó C, Salzman AL (1999) Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis. Gastroenterology 116:335-345
57. Zingarelli B, O'Connor M, Hake PW (2003) Inhibitors of poly (ADP-ribose) polymerase modulate signal transduction pathways in colitis. Eur J Pharmacol 469:183-194